NeuroSky

NeuroSky operates at the intersection of consumer electronics, neuroscience, human-computer interaction, digital health, and research tools. Its differentiation is the combination of single-lead, dry-sensor EEG hardware, ECG biosensors, proprietary biometric algorithms, SDKs, development kits, and OEM integration support. That integrated model allows the company to serve multiple customer groups, including developers, educators, researchers, wellness providers, gaming companies, and consumer-device manufacturers. The MindWave Mobile 2 Platform gives NeuroSky a consumer-facing product, while its developer and OEM platform extends the business toward embedded applications and customized products. The company also claims professional-grade EEG accuracy adapted for more accessible brain-computer-interface use. Its category exposure is nevertheless broad, spanning non-invasive BCI, wearable biosensing, education, gaming, and wellness.

NeuroSky was founded in 2004 and has developed from a brainwave-technology company into a broader biosensor platform provider. The company’s current portfolio indicates product expansion beyond EEG headsets into ECG biosensors, developer kits, SDKs, proprietary algorithms, OEM platforms, and software applications. MindWave Mobile 2 remains the consumer anchor, while products such as Effective Learner and MindLight demonstrate applications in learning and gaming. A current employee range of 51-100 and an active hiring signal suggest ongoing operating activity, although the available employee records identify only one current position and do not establish a reliable growth rate. Sector references in 2025 and 2026 show continued relevance in BCI and brain-monitoring discussions, but they do not confirm revenue growth, new funding, acquisitions, or major launches. The trajectory therefore appears durable and product-diversified, with limited evidence for acceleration.